To include your compound in the COVID-19 Resource Center, submit it here.

Biomarkers

TECHNOLOGY: Tissue markers

Tumor levels of SMARCA2 RNA could help predict responses to EZH2 inhibitors in cancers harboring mutations in the SWI/SNF complex. In

Read the full 234 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE